We're proud to share findings from a landmark multisite validation study published in The Journal of Molecular Diagnostics, demonstrating that optical genome mapping (OGM) provides exceptional accuracy for detecting structural variants in constitutional genetic disorders.
Why Validation Studies Matter
Before any new diagnostic technology can be widely adopted in clinical laboratories, it must undergo rigorous validation to ensure accuracy, reproducibility, and clinical utility. This multisite study, conducted across multiple leading academic medical centers, represents a critical step in establishing OGM as a validated clinical diagnostic tool.
Study Design and Scope
The research team, which included experts from major medical institutions across the country, analyzed a diverse collection of constitutional postnatal cases with known structural variants. The study evaluated:
- Detection rates for various types of structural variants (deletions, duplications, inversions, translocations)
- Concordance across different laboratories and operators
- Comparison with traditional cytogenetic methods (karyotyping and chromosomal microarray)
- Turnaround time and workflow efficiency
Key Findings
The study demonstrated several critical advantages of optical genome mapping:
Superior Detection Capabilities:
OGM successfully detected structural variants that were challenging or impossible to identify using conventional methods, including balanced translocations and complex rearrangements that traditional karyotyping struggles to resolve at the molecular level.
Excellent Reproducibility:
Results showed high concordance across different laboratories and technical operators, demonstrating that OGM can be reliably implemented in diverse clinical settings.
Comprehensive Genome Coverage:
Unlike targeted methods, OGM provides genome-wide assessment in a single assay, eliminating the need for multiple sequential tests and reducing diagnostic timelines.
Clinical Implications
This validation has significant implications for genetic diagnostics:
- Streamlined Testing: OGM can potentially replace multiple traditional tests with a single comprehensive assay
- Faster Diagnoses: Reduced turnaround times compared to traditional cytogenetic methods mean families receive answers more quickly
- Higher Diagnostic Yield: Detection of variants missed by conventional methods increases the likelihood of definitive diagnoses
- Better Clinical Management: More accurate genetic diagnoses enable targeted therapeutic interventions and informed family planning
Integration into Clinical Practice
At Praxis Genomics, we were among the first laboratories to recognize OGM's transformative potential and integrate it into routine clinical diagnostics. This multisite validation confirms what we've observed in our own laboratory: OGM represents a paradigm shift in how we detect and characterize structural genomic variation.
By combining OGM with whole genome sequencing and transcriptome analysis, we offer the most comprehensive genetic testing available, maximizing diagnostic success rates for patients with complex constitutional disorders.
Looking Forward
As optical genome mapping becomes more widely validated and adopted, we anticipate it will become a standard component of first-line genetic testing, particularly for cases where structural variants are suspected. This study provides the robust evidence needed to support that transition.
Read the full publication: The Journal of Molecular Diagnostics
Interested in comprehensive genetic testing that includes optical genome mapping? Contact our team to learn more.
